Command Palette
Search for a command to run...
Valiant Organics
NSE: VALIANTORGBSE: 540145CHEMICALS & PETROCHEMICALSAGROCHEMICALS
Market Cap
--
P/E Ratio
0.00
P/B Ratio
0.00
ROE
0.00%
ROA
0.00%
Debt/Equity
0.00
Book Value
₹0.0
EPS
₹0.0
About Valiant Organics
Valiant Organics is engaged in manufacturing and dealing in Speciality Chemicals and Pharmaceuticals Intermediaries in India and abroad.
Valiant Organics Limited was incorporated as 'Valiant Organics Private Limited' on February 06, 2005 in Mumbai, Maharashtra. The status of the Company was changed to a Public Limited Company and the name was changed to 'Valiant Organics Limited' vide fresh Certificate of Incorporation on July 31, 2015 by the Registrar of Companies, Mumbai, and Maharashtra. The Company is a specialty chemical manufacturing for Agro Intermediate and Pharma in India. The Company is engaged in manufacturing and marketing beneze-based specialty chemicals. These products find use in a variety of industries including agrochemicals, pharmaceuticals, dyes, pigments and veterinary medications. Its six manufacturing units in five locations, Tarapur, Sarigam, Vapi, Jhagadia and Ahmedabad are strategically close to the large ports of western India. The Company's integrated manufacturing units possess a combined installed capacity of about 70,000 MTPA across multiple chemistry domains. The Company commenced business as a partnership concern under the name 'Valiant Chemical Corporation' in 1984 and later on got converted into a Public Limited Company in 2015. It operated a single product, viz., Meta Chloroaniline, which was a major manufacturer of the same till year 1999. By 1999, the company focused on developing the in-house process technology, in order to reach the international standards of quality, and expanded the product range to also include chloro phenols, a chemical mainly used as intermediates in pharmaceuticals, pesticides, disinfectants, anti-bacterial and veterinary. Today, Valiant Organics has an ultra modern, fully equipped, quality controlled, state-of-the-art laboratory, and qualified, competent and dedicated chemists with world-class expertise. Currently, Valiant Organics Ltd. is one of the major suppliers of chloro phenols in India and abroad. Valiant Organics' production site is situated at Sarigam Industrial Estate, Gujarat, which is approximately 180 km from Nhava Sheva Port (JNPT) and 155 km from Mumbai. In 2018, as per the Scheme of Amalgamation approved by the National Company Law Tribunal (NCLT), Mumbai Bench, on January 01, 2018, Abhilasha Tex- Chem Limited (Transferor Company) got merged with the Company effective from February 21, 2018. Accordingly, the said Scheme became operational from the Appointed Date, July, 01, 2017. The Company allotted additional Equity Shares on March 15, 2018 to the Shareholders of Transferor Company in terms of the said Scheme. Listing approval for these shares was received on April 18, 2018 and Trading Approval for these shares became effective from May 25, 2018 on BSE Limited. The Company started expansion of manufacturing capacities of Chloro Phenols capacity at Sarigam and Jhagadia plant, which completed in FY 2018-19. During year 2018-19, the Company had proposed a Scheme of Merger between `Amarjyot Chemicals Limited and the Company by acquiring shares on March 8, 2019, which became effective on October 1, 2017. Company commissioned the Para Amino Phenol (PAP) project, by ramping up its production in FY 2023. It also commissioned the Pharma Intermediaries Plant in FY 2024.
Price Action • VALIANTORG
Financial Statements
Consolidated & Standalone Reports
| Metric | TTM | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 | Mar '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 759.26 | 726.87 | 680.12 | 914.52 | 954.01 | 591.14 | 588.79 | 612.41 | 122.13 | 74.88 | 53.48 | 60.24 |
Operating Expenses | 670.68 | 665.07 | 637.65 | 781.61 | 783.41 | 416.98 | 410.17 | 428.27 | 94.24 | 55.01 | 36.31 | 47.87 |
Operating Profit | 81.61 | 53.7 | 39.54 | 130.01 | 165.04 | 157.26 | 173.41 | 177.71 | 26.41 | 18.38 | 15.79 | 11.17 |
Operating Margin (%) | - | 7.39 | 5.81 | 14.22 | 17.3 | 26.6 | 29.45 | 29.02 | 21.62 | 24.54 | 29.52 | 18.55 |
Total Expenses | - | 724.46 | 691.01 | 819.78 | 817.06 | 439.1 | 424.26 | 441.55 | 96.9 | 56.98 | 37.72 | 49.3 |
EBITDA | - | 61.81 | 42.46 | 132.91 | 170.6 | 174.16 | 178.62 | 184.14 | 27.89 | 19.87 | 17.16 | 12.37 |
EBITDA Margin (%) | - | 8.5 | 6.24 | 14.53 | 17.88 | 29.46 | 30.34 | 30.07 | 22.84 | 26.54 | 32.1 | 20.54 |
Interest Expenses | 20.7 | 23.64 | 19.38 | 10.54 | 6.35 | 3.49 | 1.04 | 1.49 | 0.47 | 0.25 | 0.49 | 0.62 |
Depreciation | 37.39 | 35.76 | 33.97 | 27.63 | 27.29 | 18.63 | 13.04 | 11.8 | 2.19 | 1.71 | 0.93 | 0.82 |
Profit Before Tax (PBT) | 30.5 | 2.41 | -5.14 | 99.64 | 136.95 | 152.04 | 164.53 | 170.85 | 25.23 | 17.91 | 15.75 | 10.94 |
Tax Expenses | 8.72 | 5.41 | -2.1 | 24.06 | 34.01 | 37.45 | 40.6 | 49.58 | 8.9 | 6.29 | 5.45 | 3.66 |
PAT Before Extraordinary Items | - | -3 | -3.04 | 75.58 | 102.94 | 114.59 | 123.93 | 121.27 | 16.34 | 11.62 | 10.31 | 7.27 |
Net Profit | 21.78 | -3 | -3.04 | 75.58 | 102.94 | 114.59 | 123.93 | 133.24 | 16.34 | 11.62 | 10.31 | 7.27 |
Net Profit Margin (%) | - | -0.41 | -0.44 | 8.29 | 10.85 | 19.95 | 21.23 | 21.98 | 13.54 | 15.83 | 19.78 | 12.31 |
EPS (Adjusted) | - | -1.07 | -1.09 | 26.97 | 36.74 | 40.9 | 44.23 | 47.55 | 5.83 | 4.15 | 3.68 | 2.6 |
Valuation & Key Ratios
Performance Metrics
| Metric | TTM | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 | Mar '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Book Value Per Share | - | 236.25 | 241.12 | 245.14 | 221.97 | 184.84 | 317.5 | 427.78 | 100.91 | 124.17 | 62.5 | 587.98 |
Return on Assets (ROA) % | - | -0.27 | -0.26 | 6.83 | 9.5 | 14.23 | 19.7 | 33.14 | 16.98 | 16.96 | 25.27 | 18.33 |
Return on Equity (ROE) % | - | -0.45 | -0.45 | 11.35 | 17.07 | 22.83 | 32.12 | 53.1 | 27.6 | 25.7 | 45.29 | 33.98 |
Return on Capital Employed (ROCE) % | - | 3.47 | 1.1 | 13.86 | 19.77 | 26.01 | 34.28 | 54.77 | 40 | 35.39 | 45.08 | 37.35 |
Profitability Ratios | - | - | - | - | - | - | - | - | - | - | - | - |
Liquidity Ratios | - | - | - | - | - | - | - | - | - | - | - | - |
Valuation Ratios | - | - | - | - | - | - | - | - | - | - | - | - |
Debt to Equity Ratio | - | 0.32 | 0.32 | 0.33 | 0.51 | 0.25 | 0.27 | 0.19 | 0.01 | 0.01 | 0.04 | 0.36 |
Featured Insight
No recent news available
Key People
M
Mahek Manoj Chheda
Executive Director,Whole Time Director,Chief Financial Officer
K
Kaustubh B. Kulkarni
Company Secretary,Compliance Officer